Piper Sandler maintains Affirm Holdings at Overweight, lowers price target to $105 from $115

Piper Sandler kept Affirm Holdings at Overweight but reduced its price target to $105 from $115, an 8.7% decrease. The new target suggests a 50.7% upside from the Nov 5 close of $69.66. Recent analyst price targets for Affirm range from $79 to $103.

Original reporting
Published Nov 6, 2026, 2:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Piper Sandler maintains Affirm Holdings at Overweight, lowers price target to $105 from $115 — source image
Decision brief

The 30-second read

$AFRMBearishMed
01

Why it matters

The downgrade could trigger short‑term selling pressure and affect sentiment toward similar BNPL providers.

02

Market read

Analyst target reduction is a fresh data point that may influence trading decisions on AFRM today.

03

What to watch

Potential upside from upcoming product launches or partnership announcements not reflected in the target.

Relevance 7/10Novelty 5/10Timing: today

Background

Affirm reported a recent price target reduction by Piper Sandler, reflecting a more cautious outlook.

Company-level read

Ticker impact

$AFRMBearishHigh confidence
Context

Piper Sandler lowered its price target on Affirm Holdings from $115 to $105, an 8.7% decrease.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target cut signals reduced upside, prompting short‑term sell interest.

Market effects

May weigh on other fintech lenders as analysts reassess valuation multiples.

Limited to US equity markets; no broader regional effect.

Minimal global impact beyond U.S. fintech exposure.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity at lower levels.

Key entities

  • Piper Sandler

    Equity research firm that issued the target cut.

  • Affirm Holdings

    Fintech company providing buy‑now‑pay‑later services.

Related articles

$AFRMHighAI 8/10

Affirm Posts Its Best Quarter Ever as Visa and Mastercard Wobble

Affirm reported fiscal Q1 2027 earnings with GAAP EPS of $0.47, beating estimates, and revenue of $1.26B, up 35% YoY. Gross merchandise volume rose 34% to $14.4B. The company raised its full-year outlook, citing strong growth in its card services and active users. Affirm's performance contrasts with declines in Visa and Mastercard shares amid stablecoin concerns.

$AFRMMed

Affirm (AFRM) Q1 2027 Earnings Call Transcript

Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.

$AFRMMed

Piper Sandler lowers Affirm stock price target to $105 on valuation

Piper Sandler cut its price target on Affirm (AFRM) to $105 from $115, citing valuation changes, while raising its fiscal 2027 EPS estimate to $1.92. Affirm's Q1 results beat expectations with $1.26B revenue and $0.47 EPS, but shares fell 8% after-hours. Analysts note potential upside, with revenue growth of 32% and predicted profitability. Other analysts raised targets to $97 (Scotiabank) and $100 (Needham).

$AFRMHigh

Scotiabank raises Affirm stock price target to $97 on growth outlook

Scotiabank raised its price target on Affirm (AFRM) to $97 from $95, maintaining a Sector Outperform rating. The fintech company reported 30% gross merchandise volume growth, a 4.3% transaction cost take rate, and raised its fiscal 2027 growth floor to 30%. Affirm's Q1 2027 earnings beat expectations with $0.47 EPS on $1.26B revenue. Management noted increased allowance rates and delinquencies but highlighted better loan sale pricing.

$AFRMMed

Needham reiterates Affirm stock rating citing strong growth

Needham reiterated a Buy rating and $100 price target on Affirm (AFRM) after Q1 results beat estimates. Revenue rose 32% to $4.26B, with earnings of $5.53 per share. Affirm Card showed strong growth, but shares fell due to credit cost concerns. InvestingPro notes volatility and potential undervaluation. Q1 2027 earnings of $0.47 per share on $1.26B revenue exceeded expectations, with a 34% GMV increase.